Production of matrix metalloproteinase-9 in lipopolysaccharide-stimulated human amnion occurs through an autocrine and paracrine proinflammatory cytokine-dependent system

Biology of Reproduction

Volumn 67, Issue 6, 2002, Pages 1952-1958

  Arechavaleta Velasco, Fabian ^a   Ogando, Diego ^b   Parry, Samuel ^a   Vadillo Ortega, Felipe ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Cytokines; Parturition; Pregnancy

Indexed keywords

CYTOKINE; GELATINASE B; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIBODY; INTERLEUKIN 1;

AMNION; ARTICLE; AUTOCRINE EFFECT; CESAREAN SECTION; CHORION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; LABOR; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY; BIOSYNTHESIS; CULTURE TECHNIQUE; ENZYMOLOGY; FEMALE; IMMUNOLOGY; METABOLISM; PREGNANCY;

AMNION; ANTIBODIES; CESAREAN SECTION; CHORION; CULTURE TECHNIQUES; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 9; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842852861     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.004721     Document Type: Article

References (45)

1. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997; 11:135-176.
2. Parry S, Strauss III JF. Premature rupture of the fetal membranes. N Engl J Med 1998; 338:663-670.
3. McDonald HM, O'Loughlin JA, Jolley PT, Vigneswaran R, McDonald PJ. Changes in vaginal flora during pregnancy and association with preterm birth. J Infect Dis 1994; 170:724-728.
4. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorsgard K, McFee J. Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluation. Am J Obstet Gynecol 1995; 173:157-167.
5. Asrat T. Intra-amniotic infection in patients with preterm prelabor rupture of membranes. Pathophysiology, detection, and management. Clin Perinatol 2001; 28:735-751.
6. McGregor JA, French JI, Lawellin D, Franco-Buff A, Smith C, Todd JK. Bacterial protease-induced reduction of chorioamniotic membrane strength and elasticity. Obstet Gynecol 1987; 69:167-174.
7. Draper D, Jones W, Heine RP, Beutz M, French JI, McGregor JA. Trichomonas vaginalis weakens human amniochorion in an in vitro model of premature membrane rupture. Infect Dis Obstet Gynecol 1995; 2:267-274.
8. Terranova PE Hunter VJ, Roby KF, Hunt JS. Tumor necrosis factor-α in the female reproductive tract. Proc Soc Exp Biol Med 1995; 209:325-342.
9. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: Pivotal components of pregnancy? Biol Reprod 1996; 54:554-562.
10. Fortunato S, Menon R, Swan K. Expression of TNF-α and TNFR p55 in cultured amniochorion. Am J Reprod Immunol 1994; 32:188-193.
11. Fortunato SJ, Menon RP, Swan KF, Menon R. Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-α) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am J Obstet Gynecol 1996; 174:1855-1861.
12. Menon R, Swan K, Lyden T, Rote NS, Fortunato SJ. Expression of inflammatory cytokines (interleukin-1β and interleukin-6) in amniochorionic membranes. Am J Obstet Gynecol 1995; 172:493-500.
13. Yang Y, Yelavarthi K, Chen H, Pace J, Terranova P, Hunt J. Molecular, biochemical, and functional characteristics of tumor necrosis factor-α produced by human placental cytotrophoblastic cells. J Immunol 1993; 150:5614-5624.
14. Dudley D, Collmer D, Mitchell MD, Trautman MS. Inflammatory cytokine mRNA in human gestational tissues: Implications for term and preterm labor. J Soc Gynecol Invest 1996; 3:328-335.
15. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, Mitcell MD. Cytokine abundance in placental tissues: Evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 1999; 181:1530-1536.
16. Vadillo-Ortega F, Bermejo-Martínez L, Pfeffer F. Ruptura prematura de membranas: Mecanismos de la enfermedad. Perinatol Reprod Hum 1994; 8:180-189.
17. Fortunato S, Menon R, Lombardi S. Amniochorion gelatinase-gelatinase inhibitor imbalance in vitro: A possible infectious pathway to rupture. Obstet Gynecol 2000; 95:240-244.
18. Vadillo-Ortega F, Gonzalez-Avila G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss III JF. 92-Kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995; 146:148-156.
19. Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P, Menon R. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998; 179:1248-1253.
20. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, Bermejo L, Iwata K, Strauss III JF. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996; 174:1371-1376.
21. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318:66-69.
22. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265:13933-13938.
23. Apte SS, Mattei MG, Olsen BR. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 1994; 19:86-90.
24. Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271:30375-30380.
25. Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267:4583-4591.
26. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MTI-MMP). J Biol Chem 1998; 273:1216-1222.
27. Fortunato SJ, Menon R, Lombardi SJ. Collagenolytic enzymes (gelatinases) and their inhibitors in human amniochorionic membrane. Am J Obstet Gynecol 1997; 177:731-741.
28. Tsatas D, Baker MS, Rice GE. Differential expression of proteases in human gestational tissues before, during and after spontaneous-onset labour at term. J Reprod Fertil 1999; 116:43-49.
29. Ferrand P, Parry S, Sammel M, Macones G, Kuivaniemi H, Romero R, Strauss JFI. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002; 8:494-501.
30. Katsura M, Ito A, Hirakawa S, Mori Y. Human recombinant interleukin-1 α increases biosynthesis of collagenase and hyaluronic acid in cultured human chorionic cells. FEBS Lett 1989; 244:315-318.
31. So T, Ito A, Sato T, Mori Y, Hirakawa S. Tumor necrosis factor-α stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol Reprod 1992; 46:772-778.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T. Nature 1970; 227:680-684.
33. Harlow E, Lane D. Antibodies. A Laboratory Manual. New York: Cold Spring Harbor Laboratory; 1988.
34. Lei H, Vadillo-Ortega E, Paavola LG, Strauss III JF. 92-kDa gelatinase (matrix metalloproteinase-9) is induced in rat amnion immediately prior to parturition. Biol Reprod 1995; 53:339-344.
35. Halgunset J, Johnsen H, Kjøllesdal A, Qvigstad E, Espevik T, Anstgulen R. Cytokine levels in amniotic fluid and inflammatory changes in the placenta from normal deliveries at term. Eur J Obstet Gynecol Reprod Biol 1994; 56:153-160.
36. Imseis HM, Greig PC, Livengood CHR, Shunior E, Durda P, Erikson M. Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. J Soc Gynecol Invest 1997; 4:90-94.
37. Vadillo-Ortega F, Sadowsky D, Haluska G, Hernandez C, Guevara R, Gravett M, Novy MJ. Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1β infusion in pregnant rhesus monkeys. Am J Obstet Gynecol 2002; 186:128-138.
38. Riley SC, Leask R, Denison FC, Wisely K, Calder AA, Howe DC. Secretion of tissue inhibitors of matrix metalloproteinases by human fetal membranes, decidua and placenta at parturition. J Endocrinol 1999; 162:351-359.
39. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988; 31:553-584.
40. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274:21491-21494.
41. Fridman R, Toth M, Peña D, Mobashery S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 1995; 55:2548-2555.
42. Hahn-Dantona E, Ramos-DeSimone N, Sipley J, Nagase H, French DL, Quigley JP. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases. Ann N Y Acad Sci 1999; 878:372-387.
43. Milwidsky A, Finci Z, Mayer M. Plasminogen activator activity and urokinase inhibitor activity in human amniotic fluid and fetal membranes. Clin Biochem 1988; 21:301-306.
44. Fortunato SJ, Menon R, Lombardi SJ. MMP/TIMP imbalance in amniotic fluid during PROM: An indirect support for endogenous pathway to membrane rupture. J Perinat Med 1999; 27:362-368.
45. Fortunato SJ, Menon R, Lombardi SJ. Stromelysins in placental memranes and amniotic fluid with premature rupture of membranes. Obstet Gynecol 1999; 94:435-440.